Navigation Links
3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
Date:11/8/2007

ng collaboration.

"Food safety remains an important growth platform for 3M," said Chuck Kummeth, vice president and general manager, 3M Medical Division. "But we have chosen to focus on opportunities other than molecular food testing that are more economically attractive. This decision does not affect our separate partnership with Gen-Probe to develop nucleic acid tests to detect dangerous healthcare-associated infections such as methicillin-resistant Staphylococcus aureus (MRSA)."

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 24 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions, future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as believe, will, expect, anticipate, estimate, intend, plan and would. For example, statements concerning management's objectives and future growth are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. Some of the risks, uncertainties and
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. A new molecular zip code, and a new drug target for Huntingtons disease
2. New knock-out gene model provides molecular clues to breast cancer
3. Molecular probe paints cancer cells in living animals, Stanford researchers find
4. Story ideas from molecular & cellular proteomics
5. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
8. Molecular profiling can accurately predict survival in colon cancer patients
9. Xceed Molecular Names Fran Tuttle to Its Board of Trustees
10. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
11. Xceed Molecular Launches Ziplex(R) Automated Gene-Expression System at the Association for Molecular Pathology, Booth 84/85
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 2HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 3Van Andel Institute Cuts Ribbon on $178 Million Expansion 4Genetic changes shown to be important indicators for disease progression in cervical cancer patients 61278 13SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 13SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 23SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 33SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 43SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 53SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 63SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 73SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 83SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 93SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 103SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 113SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 123SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 133SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 143SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 153SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 163SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 173SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 183SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 193SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 203SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 21Vivakor Presents at Nutraceutical Event 61275 1Vivakor Presents at Nutraceutical Event 61275 2Vivakor Presents at Nutraceutical Event 61275 3Vivakor Presents at Nutraceutical Event 61275 4Vivakor Presents at Nutraceutical Event 61275 5Vivakor Presents at Nutraceutical Event 61275 6